Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
150M
-
Shares change
-
+7.79M
-
Total reported value, excl. options
-
$1.5B
-
Value change
-
+$81.4M
-
Put/Call ratio
-
0
-
Number of buys
-
130
-
Number of sells
-
-101
-
Price
-
$10.01
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2025
275 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q3 2025.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 150M shares
of 316M outstanding shares and own 47.33% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18M shares), BlackRock, Inc. (14.1M shares), Rubric Capital Management LP (12.3M shares), TPG GP A, LLC (12.3M shares), CITADEL ADVISORS LLC (5.73M shares), DIMENSIONAL FUND ADVISORS LP (5.43M shares), Nantahala Capital Management, LLC (4.22M shares), GEODE CAPITAL MANAGEMENT, LLC (4.03M shares), STATE STREET CORP (3.97M shares), and NEUBERGER BERMAN GROUP LLC (3.72M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.